Abstract
Hepatic encephalopathy (HE) is cerebral dysfunction caused by liver failure and inflicts 30-40% of patients with liver cirrhosis during their disease course. Clinically manifest HE is often preceded by minimal HE (MHE) — a clinically undetectable cognitive disturbance closely associated with loss of quality of life. Accordingly, detecting and treating MHE improve the patients’ daily functioning and prevent HE-related hospital admissions. The scope of this review article is to create an overview of the validation level and usage of psychometric tests used to detect MHE: Portosystemic hepatic encephalopathy test, continuous reaction time test, Stroop EncephalApp, animal naming test, critical flicker frequency test, and inhibitory control test. Our work is aimed at the clinician or scientist who is about to decide on which psychometric test would fit best in their clinic, cohort, or study. First, we outline psychometric test validation obstacles and requirements. Then, we systematically approach the literature on each test and select well-conducted studies to answer the following questions:
• Which percentage of patients with cirrhosis does the test deem as having MHE?
• Is the test able to predict clinically manifest HE?
• Is there a well-known test-retest variation and inter-observer variation?
• Is the test able to detect a treatment response?
• Is the test result affected by age, educational level, gender, or comorbidities?
Similar content being viewed by others
References
Acharya C, Wade JB, Fagan A, White M, Gavis E, Ganapathy D, Gilles H, Heuman DM, Bajaj JS (2017) Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation. Liver Transpl 23(11):1396–1403. https://doi.org/10.1002/lt.24864
Acharya C, White MB, Fagan A, Sterling RK, Stravitz RT, Puri P, Fuchs M, Luketic V, Sanyal AJ, Wade JB, Gilles HC, Heuman DM, Tinsley F, Matherly S, Lee H, Siddiqui MS, Thacker LR, Bajaj JS (2021) Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls. Dig Dis Sci 66(4):1360–1366. https://doi.org/10.1007/s10620-020-06261-y
Agarwal A, Taneja S, Chopra M, Duseja A, Dhiman RK (2020) Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy. Clin Exp Hepatol 6(2):116–124. https://doi.org/10.5114/ceh.2019.95105
Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, Bouneva I, Puri P, Luketic V, Sanyal AJ, Gilles H, Heuman DM and Bajaj JS (2013). Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol 59(3): 467-473. https://www.ncbi.nlm.nih.gov/pubmed/23665182
Ahn JM, Kim CH, Um SH, Kim KM, Kim TH, Yim SY, Choi HS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS (2017) Validation study associating glutaminase promoter variations with hepatic encephalopathy in East Asian populations. Journal of Gastroenterology and Hepatology (Australia) 32(4):901–907. https://doi.org/10.1111/jgh.13618
Allampati S, Duarte-Rojo A, Thacker LR, Patidar KR, White MB, Klair JS, John B, Heuman DM, Wade JB, Flud C, O'Shea R, Gavis EA, Unser AB, Bajaj JS (2016). Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. Am J Gastroenterol 111(1): 78-86. https://www.ncbi.nlm.nih.gov/pubmed/26644276
Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli, P, Gatta A (2008). Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 49(3): 346-353. https://www.journal-of-hepatology.eu/article/S0168-8278(08)00352-8/fulltext
Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19(3-4): 253-267. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15554421
Amodio P, Montagnese S, Spinelli G, Schiff S, Mapelli D (2017) Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy. Metab Brain Dis 32(4):1287–1293. https://doi.org/10.1007/s11011-017-0032-2
Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010). Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139(2): 510-518, 518.e511-512. https://pubmed.ncbi.nlm.nih.gov/20470775/
Amodio P, Schiff S, Del Piccolo F, Mapelli D, Gatta A, Umiltà C (2005) Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing. Metab Brain Dis 20(2): 115-127. https://www.ncbi.nlm.nih.gov/pubmed/15938130
Ampuero J, Montoliú C, Simón-Talero M, Aguilera V, Millán R, Márquez C, Jover R, Rico MC, Sendra C, Serra MÁ, Romero-Gómez M (2018). Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression. Journal of Gastroenterology and Hepatology (Australia) 33(3): 718-725. https://pubmed.ncbi.nlm.nih.gov/28768371/
Ampuero J, Simón M, Montoliú C, Jover R, Serra MÁ, Córdoba, J. and Romero-Gómez, M. (2015). Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated with Survival of Patients with Cirrhosis. Gastroenterology 149(6): 1483-1489. https://pubmed.ncbi.nlm.nih.gov/26299413/
Badea MA, Drug VL, Dranga M, Gavrilescu O, Stefanescu G, Popa I, Mihai C, Cijevschi-Prelipcean C (2016). Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES). Metab Brain Dis 31(6): 1463-1471. https://pubmed.ncbi.nlm.nih.gov/27461111/
Bajaj JS (2008). Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 14(23): 3609-3615. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18595126
Bajaj, J. S., Duarte-Rojo, A., Xie, J. J., Acharya, C., Wade, J. B., Robles, C., Thacker, L. R., Flud, C., Fagan, A., Garcia-Saenz-de-Sicilia, M., White, M. B., Kelly, M., Nguyen, V., Gavis, E. A. and Vargas, H. E. (2020). Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clin Gastroenterol Hepatol 18(13): 3008-3016.e3002. https://pubmed.ncbi.nlm.nih.gov/32205222/
Bajaj JS, Etemadian A, Hafeezullah M, Saeian K (2007a). Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology 45(3): 833-834. https://www.ncbi.nlm.nih.gov/pubmed/17326210
Bajaj JS, Fagan A, Sikaroodi M, White MB, Sterling RK, Gilles H, Heuman D, Stravitz RT, Matherly SC, Siddiqui MS, Puri P, Sanyal AJ, Luketic V, John B, Fuchs M, Ahluwalia V and Gillevet PM (2017a) Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. Liver Transpl 23(7): 907-914. https://www.ncbi.nlm.nih.gov/pubmed/28240840
Bajaj, J. S., Fagan, A., White, M. B., Wade, J. B., Hylemon, P. B., Heuman, D. M., Fuchs, M., John, B. V., Acharya, C., Sikaroodi, M. and Gillevet, P. M. (2019). Specific Gut and Salivary Microbiota Patterns Are Linked with Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy. American Journal of Gastroenterology 114(7): 1080-1090. https://pubmed.ncbi.nlm.nih.gov/30816877/
Bajaj, J. S., Hafeezullah, M., Franco, J., Varma, R. R., Hoffmann, R. G., Knox, J. F., Hischke, D., Hammeke, T. A., Pinkerton, S. D. and Saeian, K. (2008). Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 135(5): 1591-1600.e1591. doi: https://doi.org/10.1053/j.gastro.2008.07.021
Bajaj, J. S., Heuman, D. M., Sterling, R. K., Sanyal, A. J., Siddiqui, M., Matherly, S., Luketic, V., Stravitz, R. T., Fuchs, M., Thacker, L. R., Gilles, H., White, M. B., Unser, A., Hovermale, J., Gavis, E., Noble, N. A. and Wade, J. B. (2015). Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol 13(10): 1828-1835 e1821. https://www.ncbi.nlm.nih.gov/pubmed/24846278
Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ, Kheradman R, Heuman D, Wang J, Gurry T, Williams R, Sikaroodi M, Fuchs M, Alm E, John B, Thacker LR, Riva A, Smith M, Taylor-Robinson SD, Gillevet PM (2017b). Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial. Hepatology. https://www.ncbi.nlm.nih.gov/pubmed/28586116
Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007b). Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102(4): 754-760. https://www.ncbi.nlm.nih.gov/pubmed/17222319
Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Luketic V, White MB, Sanyal AJ (2010). Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 138(7): 2332-2340. https://www.ncbi.nlm.nih.gov/pubmed/20178797
Bajaj, J. S., Thacker, L. R., Heuman, D. M., Fuchs, M., Sterling, R. K., Sanyal, A. J., Puri, P., Siddiqui, M. S., Stravitz, R. T., Bouneva, I., Luketic, V., Noble, N., White, M. B., Monteith, P., Unser, A. and Wade, J. B. (2013). The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology 58(3): 1122-1132. https://www.ncbi.nlm.nih.gov/pubmed/23389962
Bale, A., Pai, C. G., Shetty, S., Balaraju, G. and Shetty, A. (2018). Prevalence of and Factors Associated With Minimal Hepatic Encephalopathy in Patients With Cirrhosis of Liver. J Clin Exp Hepatol 8(2): 156-161. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992259/
Bao, Z. J., Qiu, D. K., Ma, X., Fan, Z. P., Zhang, G. S., Huang, Y. Q., Yu, X. F. and Zeng, M. D. (2007). Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 13(21): 3003-3008. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171157/
Barone M, Shahini E, Iannone A, Viggiani MT, Corvace V, Principi M, Di Leo A (2018) Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Dig Liver Dis 50(5):496–500. https://doi.org/10.1016/j.dld.2018.01.133
Bisiacchi, P., Cona, G., Tarantino, V., Schiff, S., Montagnese, S., Amodio, P. and Capizzi, G. (2014). Assessing inter- and intra-individual cognitive variability in patients at risk for cognitive impairment: the case of minimal hepatic encephalopathy. Metab Brain Dis 29(4): 945-953. https://www.ncbi.nlm.nih.gov/pubmed/24682793
Burkard T, Biedermann A, Herold C, Dietlein M, Rauch M, Diefenbach M (2013) Treatment with a potassium-iron-phosphate-citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy: a multicenter, randomized, placebo-controlled, double-blind clinical trial. Eur J Gastroenterol Hepatol 25(3):352–358. https://doi.org/10.1097/MEG.0b013e32835afaa5
Burroughs TK, Wade JB, Ellwood MS, Fagan A, Heuman DM, Fuchs M, Bajaj JS (2018) Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans. Dig Dis Sci 63(2):481–485. https://doi.org/10.1007/s10620-017-4894-2
Campagna, F., Montagnese, S., Ridola, L., Senzolo, M., Schiff, S., De Rui, M., Pasquale, C., Nardelli, S., Pentassuglio, I., Merkel, C., Angeli, P., Riggio, O. and Amodio, P. (2017). The animal naming test: An easy tool for the assessment of hepatic encephalopathy. Hepatology 66(1): 198-208. https://www.ncbi.nlm.nih.gov/pubmed/28271528
Chen HJ, Jiang LF, Sun T, Liu J, Chen QF, Shi HB (2015). Resting-state functional connectivity abnormalities correlate with psychometric hepatic encephalopathy score in cirrhosis. Eur J Radiol 84(11): 2287-2295. https://www.ejradiology.com/article/S0720-048X(15)30078-4/fulltext
Chen QF, Zou TX, Yang ZT, Chen HJ (2020) Identification of patients with and without minimal hepatic encephalopathy based on gray matter volumetry using a support vector machine learning algorithm. Scientific reports 10(1). https://doi.org/10.1038/s41598-020-59433-1
Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, Irwig L, Levine D, Reitsma JB, de Vet HCW, Bossuyt PMM (2016). STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open 6(11): e012799. http://bmjopen.bmj.com/content/6/11/e012799.abstract
Corrias M, Turco M, Rui MD, Gatta A, Angeli P, Merkel C, Amodio P, Schiff S, Montagnese S (2014). Covert hepatic encephalopathy: does the mini-mental state examination help? J Clin Exp Hepatol 4(2): 89-93. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116703/pdf/main.pdf
Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y (2010). Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 55(8): 2381-2390. https://www.ncbi.nlm.nih.gov/pubmed/20508990
Duarte-Rojo, A., Allampati, S., Thacker, L. R., Flud, C. R., Patidar, K. R., White, M. B., Klair, J. S., Heuman, D. M., Wade, J. B., Gavis, E. A. and Bajaj, J. S. (2019). Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. Metab Brain Dis 34(1): 289-295. https://www.ncbi.nlm.nih.gov/pubmed/30506333
Duarte-Rojo, A., Estradas, J., Hernandez-Ramos, R., Ponce-de-Leon, S., Cordoba, J. and Torre, A. (2011). Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci 56(10): 3014-3023. http://www.ncbi.nlm.nih.gov/pubmed/21461913
Elsass P (1984) Number Connection Test and Continuous Reaction Times in assesment of Organic and Metabolic Encephalopathy: A Comparative Study. Acta pharmacol et toxicol 54:115–119. https://doi.org/10.1111/j.1600-0773.1984.tb01903.x
Flud, C. R. and Duarte-Rojo, A. (2019). Prognostic Implications of Minimal/Covert Hepatic Encephalopathy: Large-scale Validation Cohort Studies. J Clin Exp Hepatol 9(1): 112-116. https://www.ncbi.nlm.nih.gov/pubmed/30765944
Formentin C, De Rui M, Zoncape M, Ceccato S, Zarantonello L, Senzolo M, Burra P, Angeli P, Amodio P, Montagnese S (2019) The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability. J Hepatol 70(4):648–657. https://doi.org/10.1016/j.jhep.2018.12.031
Formentin C, Zarantonello L, Mangini C, Frigo AC, Montagnese S, Merkel C (2021) Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE). Liver International. https://doi.org/10.1111/liv.14785
Gabriel MM, Kircheis G, Hardtke S, Markwardt D, Buggisch P, Mix H, Grüngreiff K, Welzel TM, Kälsch J, Hartmann H, Gerbes AL, Karpowitz MV, Seeliger B, Wedemeyer H, Weissenborn K (2020) Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. Eur J Gastroenterol Hepatol. https://doi.org/10.1097/MEG.0000000000001822
Gencdal G, Gunsar F, Meral CE, Salman E, Gürsel B, Oruç N, Karasu Z, Ersoz G, Akarca US (2014) Diurnal changes of critical flicker frequency in patients with liver cirrhosis and their relationship with sleep disturbances. Dig Liver Dis 46(12):1111–1115. https://doi.org/10.1016/j.dld.2014.08.031
Giménez-Garzó C, Garcés JJ, Urios A, Mangas-Losada A, García-García R, González-López O, Giner-Durán R, Escudero-García D, Serra MA, Soria E, Felipo V, Montoliu C (2017) The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLoS One 12(2):e0171211. https://doi.org/10.1371/journal.pone.0171211
Goldbecker, A., Weissenborn, K., Hamidi Shahrezaei, G., Afshar, K., Rumke, S., Barg-Hock, H., Strassburg, C. P., Hecker, H. and Tryc, A. B. (2013). Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 62(10): 1497-1504. https://www.ncbi.nlm.nih.gov/pubmed/23297006
Greinert, R., Ripoll, C., Hollenbach, M. and Zipprich, A. (2016). Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach. Aliment Pharmacol Ther 44(5): 514-521. https://www.ncbi.nlm.nih.gov/pubmed/27385440
Greinert, R., Ripoll, C. and Zipprich, A. (2018). Covert hepatic encephalopathy leads to distinct alterations in the emotional state, independently of MELD-Score. Z Gastroenterol 56(5): 461-468. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0043-123766
Grover VPB, McPhail MJW, Wylezinska-Arridge M, Crossey MME, Fitzpatrick JA, Southern L, Saxby BK, Cook NA, Cox IJ, Waldman AD, Dhanjal NS, Bak-Bol A, Williams R, Morgan MY, Taylor-Robinson SD (2017) A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy. Metab Brain Dis 32(1):77–86. https://doi.org/10.1007/s11011-016-9881-3
Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A. and Chawla, Y. (2010). Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 53(5): 849-855. https://www.journal-of-hepatology.eu/article/S0168-8278(10)00616-1/fulltext
Gupta D, Ingle M, Shah K, Phadke A, Sawant P (2015) Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent. J Dig Dis 16(7):400–407. https://doi.org/10.1111/1751-2980.12248
Hartmann, I. J., Groeneweg, M., Quero, J. C., Beijeman, S. J., de Man, R. A., Hop, W. C. and Schalm, S. W. (2000). The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 95(8): 2029-2034. https://www.ncbi.nlm.nih.gov/pubmed/10950053
Irimia, R., Stanciu, C., Cojocariu, C., Sfarti, C. and Trifan, A. (2013). Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. J Gastrointestin Liver Dis 22(3): 277-281. https://pubmed.ncbi.nlm.nih.gov/24078984/
Jackson, C. D., Gram, M., Halliday, E., Olesen, S. S., Sandberg, T. H., Drewes, A. M. and Morgan, M. Y. (2016). New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy. Clin Neurophysiol 127(8): 2933-2941. https://www.ncbi.nlm.nih.gov/pubmed/27236607
Jagtap N, Bhakhar P, Miftahussurur MSYH, Shrimal P, Sharma M, Gupta R, Rao PN, Reddy DN (2021). Minimal Hepatic Encephalopathy in Patients with Alcohol Related and Non-alcoholic Steatohepatitis Related Cirrhosis by Psychometric Hepatic Cephalopathy Score and Critical Flicker Frequency. Acta medica Indonesiana 53(1): 24-30. https://pubmed.ncbi.nlm.nih.gov/33818404/
Jensen AR, Rohwer WD Jr (1966) The Stroop color-word test: a review. Acta Psychol (Amst) 25(1):36–93. https://doi.org/10.1016/0001-6918(66)90004-7
Jeong JY, Jun DW, Bai D, Kim JY, Sohn JH, Ahn SB, Kim SG, Kim TY, Kim HS, Jeong SW, Cho YK, Song DS, Kim HY, Jung YK, Yoon EL (2017) Validation of a paper and pencil test battery for the diagnosis of minimal hepatic encephalopathy in Korea. Journal of Korean Medical Science 32(9):1484–1490. https://doi.org/10.3346/jkms.2017.32.9.1484
Kappus MR, Bajaj JS (2012) Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol 10(11):1208–1219. https://doi.org/10.1016/j.cgh.2012.05.026
Khodadoostan, M., Sadeghian, S., Safaei, A., Kabiri, M., Shavakhi, S., Shavakhi, A. R. and Shavakhi, A. (2018). Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis. Middle East J Dig Dis 10(4): 230-235. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488500/
Kimer, N., Gluud, L. L., Pedersen, J. S., Tavenier, J., Møller, S. and Bendtsen, F. (2021). The psychometric hepatic encephalopathy syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis. Translational Gastroenterology and Hepatology 6. https://pubmed.ncbi.nlm.nih.gov/33409402/
Kimer N, Pedersen JS, Busk TM, Gluud LL, Hobolth L, Krag A, Møller S, Bendtsen F (2017) Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial. Hepatology 65(2):592–603. https://doi.org/10.1002/hep.28898
Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D (2007) Assessment of low-grade hepatic encephalopathy: A critical analysis. J Hepatol 47(5):642–650. https://doi.org/10.1016/j.jhep.2007.05.019
Kircheis, G., Hilger, N. and Häussinger, D. (2014). Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Gastroenterology 146(4): 961-969. https://www.ncbi.nlm.nih.gov/pubmed/24365582
Kircheis, G., Wettstein, M., Timmermann, L., Schnitzler, A. and Haussinger, D. (2002). Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35(2): 357-366. https://www.ncbi.nlm.nih.gov/pubmed/11826409
Kondo Y, Iwasa M, Kawaratani H, Miyaaki H, Hanai T, Kon K, Hirano H, Shimizu M, Yoshiji H, Okita K, Koike K (2021) Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study. Hepatology research : the official journal of the Japan Society of Hepatology 51(6):674–681. https://doi.org/10.1111/hepr.13629
Kraglund F, Jepsen P, Amanavicius N, Aagaard NK (2019) Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience. Scand J Gastroenterol 54(7):899–904. https://doi.org/10.1080/00365521.2019.1630675
Labenz, C., Adarkwah, C. C., Wörns, M. A., Miehlke, S., Hofmann, W. P., Buggisch, P., Galle, P. R., Frieling, T. and Labenz, J. (2020a). Management of hepatic encephalopathy in Germany: a survey among physicians. Z Gastroenterol 58(1): 49-56. https://pubmed.ncbi.nlm.nih.gov/31931540/
Labenz C, Baron JS, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR and Wörns MA (2018). Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients. Aliment Pharmacol Ther 48(3): 313-321. https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.14824
Labenz C, Beul L, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Wörns MA (2019a) Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy. Eur J Intern Med 60:96–100 https://pubmed.ncbi.nlm.nih.gov/30131209/
Labenz, C., Toenges, G., Huber, Y., Nagel, M., Marquardt, J. U., Schattenberg, J. M., Galle, P. R., Labenz, J. and Worns, M. A. (2019b). Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis. Am J Gastroenterol 114(5): 764-770. https://www.ncbi.nlm.nih.gov/pubmed/30848730
Labenz, C., Toenges, G., Huber, Y., Nagel, M., Marquardt, J. U., Schattenberg, J. M., Galle, P. R., Labenz, J. and Wörns, M. A. (2019c). Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy. Aliment Pharmacol Ther 50(10): 1112-1119. https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.15515
Labenz, C., Toenges, G., Schattenberg, J. M., Nagel, M., Huber, Y., Marquardt, J. U., Labenz, J., Galle, P. R. and Wörns, M. A. (2020b). Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies. Clin Transl Gastroenterol 11(6): e00172. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339190/
Labenz C, Toenges G, Schattenberg JM, Nagel M, Sprinzl MF, Nguyen-Tat M, Zimmermann T, Huber Y, Marquardt JU, Galle PR, Worns MA (2019d). Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy. J Clin Gastroenterol 53(7): e303-e307. https://pubmed.ncbi.nlm.nih.gov/30439761/
Lauridsen MM, Bajaj JS (2015) Hepatic encephalopathy treatment and its effect on driving abilities: A continental divide. J Hepatol 63(1): 287-288. http://www.ncbi.nlm.nih.gov/pubmed/25796480
Lauridsen MM, Frojk J, de Muckadell OB, Vilstrup H (2014). Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons. Metab Brain Dis 29(3): 655-660. https://www.ncbi.nlm.nih.gov/pubmed/25008562
Lauridsen MM, Gronbaek H, Naeser EB, Leth ST, Vilstrup H (2012). Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis 27(4): 559-565. https://www.ncbi.nlm.nih.gov/pubmed/22614824
Lauridsen MM, Jepsen P and Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2): 135-139. https://www.ncbi.nlm.nih.gov/pubmed/21484318
Lauridsen MM, Jepsen P, Wernberg CW, Schaffalitzky de Muckadell OB, Bajaj JS, Vilstrup H (2020). Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy. Hepatol Commun 4(9): 1353-1361. https://pubmed.ncbi.nlm.nih.gov/32923838/
Lauridsen MM, Mikkelsen S, Svensson T, Holm J, Kluver C, Gram J, Vilstrup H, Schaffalitzky de Muckadell OB. (2017). The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study. PLoS One 12(10): e0185412. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636096/
Lauridsen, M. M., Poulsen, L., Rasmussen, C. K., Hogild, M., Nielsen, M. K., de Muckadell, O. B. and Vilstrup, H. (2016). Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy. Metab Brain Dis 31(2): 267-272. https://www.ncbi.nlm.nih.gov/pubmed/26435407
Lauridsen, M. M., Schaffalitzky de Muckadell, O. B. and Vilstrup, H. (2015). Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests. Metab Brain Dis 30(5): 1187-1192. https://www.ncbi.nlm.nih.gov/pubmed/26016624
Li, S. W., Wang, K., Yu, Y. Q., Wang, H. B., Li, Y. H. and Xu, J. M. (2013). Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World J Gastroenterol 19(46): 8745-8751. http://www.ncbi.nlm.nih.gov/pubmed/24379595
Li, W., Li, N., Wang, R., Li, Q. and Wu, H. (2015). Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients. Hepatology International 9(2): 218-223. https://link.springer.com/article/10.1007%2Fs12072-015-9610-8
Lunia, M. K., Sharma, B. C. and Sachdeva, S. (2013). Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy. Hepatology International 7(1): 268-273. https://pubmed.ncbi.nlm.nih.gov/26201641/
Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S. and Srivastava, S. (2014). Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 12(6): 1003-1008.e1001. http://www.ncbi.nlm.nih.gov/pubmed/24246768
Luo, M., Yu, X. B., Hu, S. J. and Bai, F. H. (2020). EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis. Saudi J Gastroenterol 26(3): 120-128. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392289/
Machado Júnior PAB, Ziliotto RD, Ferreira APVN, Buson TM, Do Couto CM, Pissaia Junior A (2020) Use of the stroop encephalapp for covert hepatic encephalopathy screening in cirrhotic patients in Southern Brazil. Arquivos de Gastroenterologia 57(4):399–403. https://doi.org/10.1590/S0004-2803.202000000-73
Maldonado-Garza, H. J., Vázquez-Elizondo, G., Gaytán-Torres, J. O., Flores-Rendón, A. R., Cárdenas-Sandoval, M. G. and Bosques-Padilla, F. J. (2011). Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Ann Hepatol 10 Suppl 2: S40-44. https://www.ncbi.nlm.nih.gov/pubmed/22228880
Marchesini, G., Bianchi, G., Amodio, P., Salerno, F., Merli, M., Panella, C., Loguercio, C., Apolone, G., Niero, M. and Abbiati, R. (2001). Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 120(1): 170-178. https://pubmed.ncbi.nlm.nih.gov/11208726/
Mardini, H., Saxby, B. K. and Record, C. O. (2008). Computerized Psychometric Testing in Minimal Encephalopathy and Modulation by Nitrogen Challenge and Liver Transplant. Gastroenterology 135(5): 1582-1590. https://pubmed.ncbi.nlm.nih.gov/18647604/
Metwally MA, Biomy HA, Omar MZ, Sakr AI (2019). Critical flickering frequency test: a diagnostic tool for minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 31(8): 1030-1034. https://pubmed.ncbi.nlm.nih.gov/31274595/
Mina A, Moran S, Ortiz-Olvera N, Mera R, Uribe M (2014). Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis. Hepatol Res 44(10): E92-99. http://www.ncbi.nlm.nih.gov/pubmed/24033755
Montagnese, S. and Bajaj, J. S. (2019). Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues. Drugs 79(Suppl 1): 11-16. https://www.ncbi.nlm.nih.gov/pubmed/30706419
Montagnese S, Biancardi A, Schiff S, Carraro P, Carlà V, Mannaioni G, Moroni F, Tono N, Angeli P, Gatta A, Amodio P (2011). Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 53(2): 558-566. http://www.ncbi.nlm.nih.gov/pubmed/21274876
Montagnese S, Schiff S, Turco M, Bonato CA, Ridola L, Gatta A, Nousbaum JB, Riggio O, Merkel C, Amodio P (2012) Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy. Dig Liver Dis 44(11): 957-960. http://www.ncbi.nlm.nih.gov/pubmed/22819289
Montoliu C, Cauli O, Urios A, ElMlili N, Serra MA, Giner-Duran R, González-Lopez O, Del Olmo JA, Wassel A, Rodrigo JM, Felipo V (2011) 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 106(9): 1629-1637. https://pubmed.ncbi.nlm.nih.gov/21483460/
Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Urios A, Rodrigo JM, Felipo V (2009). IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 43(3): 272-279. https://pubmed.ncbi.nlm.nih.gov/18562979/
Moratalla, A., Ampuero, J., Bellot, P., Gallego-Durán, R., Zapater, P., Roger, M., Figueruela, B., Martínez-Moreno, B., González-Navajas, J. M., Such, J., Romero-Gómez, M. and Francés, R. (2017). Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver Int 37(2): 212-223. https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.13200
Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K (2016). Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis 31(6): 1217-1229. https://www.ncbi.nlm.nih.gov/pubmed/26412229
Moscucci F, Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Merli M, Riggio O (2011). Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver International 31(10): 1505-1510. https://pubmed.ncbi.nlm.nih.gov/22093325/
Nardelli S, Allampati S, Riggio O, Mullen KD, Prakash R, Gioia S, Unser A, White MB, Fagan AC, Wade JB, Farcomeni A, Gavis EA, Bajaj JS (2017). Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study. Dig Dis Sci 62(3): 794-800. https://www.ncbi.nlm.nih.gov/pubmed/28039670
Nardelli, S., Gioia, S., Pasquale, C., Pentassuglio, I., Farcomeni, A., Merli, M., Salvatori, F. M., Nikolli, L., Torrisi, S., Greco, F., Nicoletti, V. and Riggio, O. (2016). Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. American Journal of Gastroenterology 111(4): 523-528. https://pubmed.ncbi.nlm.nih.gov/26925879/
Nardelli, S., Gioia, S., Ridola, L., Farcomeni, A., Merli, M. and Riggio, O. (2019a). Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis. Hepatology 70(2): 640-649. https://pubmed.ncbi.nlm.nih.gov/30289992/
Nardelli, S., Lattanzi, B., Merli, M., Farcomeni, A., Gioia, S., Ridola, L. and Riggio, O. (2019b). Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis. Hepatology 70(5): 1704-1713. https://pubmed.ncbi.nlm.nih.gov/31038758/
Olesen, S. S., Jackson, C. D., Gram, M., Zacharias, H. D., Dirks, M., Weissenborn, K., Drewes, A. M. and Morgan, M. Y. (2019). Cortical networks are disturbed in people with cirrhosis even in the absence of neuropsychometric impairment. Clin Neurophysiol 130(3): 419-427. https://pubmed.ncbi.nlm.nih.gov/30552046/
Osman MA, Sayed MM, Mansour KA, Saleh SA, Ibrahim WA, Abdelhakam SM, Bahaa M, Yousry WA, Elbaz HS, Mikhail RN, Hassan AM, Elsayed EH, Mahmoud DA (2016). Reversibility of minimal hepatic encephalopathy following liver transplantation in Egyptian cirrhotic patients. World J Hepatol 8(30): 1279-1286. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084057/pdf/WJH-8-1279.pdf
Patidar, K. R., Thacker, L. R., Wade, J. B., Sterling, R. K., Sanyal, A. J., Siddiqui, M. S., Matherly, S. C., Stravitz, R. T., Puri, P., Luketic, V. A., Fuchs, M., White, M. B., Noble, N. A., Unser, A. B., Gilles, H., Heuman, D. M. and Bajaj, J. S. (2014). Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol 109(11): 1757-1763. https://www.ncbi.nlm.nih.gov/pubmed/25178701
Pawar, V. B., Surude, R. G., Sonthalia, N., Zanwar, V., Jain, S., Contractor, Q. and Rathi, P. M. (2019). Minimal Hepatic Encephalopathy in Indians: Psychometric Hepatic Encephalopathy Score and Inhibitory Control Test for Diagnosis and Rifaximin or Lactulose for Its Reversal. J Clin Transl Hepatol 7(4): 304-312. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943207/
Pflugrad H, Bronzlik P, Raab P, Tryc AB, Goldbecker A, Barg-Hock H, Strassburg CP, Ding XQ, Lanfermann H, Weissenborn K (2015). Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders? Liver Int 35(7): 1816-1823. https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.12771
Philonenko S, Rivière P, Mallet M, Poullenot F, Tripon S, Munteanu M, Boukherrouf R, Sultanik P, Roupret M, Thabut D, Rudler M (2019) Neurocognitive impairment is associated with erectile dysfunction in cirrhotic patients. Digestive and Liver Disease 51(6):850–855. https://doi.org/10.1016/j.dld.2019.03.030
Qu Y, Li T, Lin C, Liu F, Wu S, Wang L, Ye Q (2021) Animal naming test for the assessment of minimal hepatic encephalopathy in Asian cirrhotic populations. Clin Res Hepatol Gastroenterol 45(5):101729. https://doi.org/10.1016/j.clinre.2021.101729
Rai R, Ahuja CK, Agrawal S, Kalra N, Duseja A, Khandelwal N, Chawla Y, Dhiman RK (2015). Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. Clin Transl Gastroenterol 6(9): e111. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816249/
Rathi S, Chopra M, Chouduri G, Sharma P, Madan K, Chhabra M, Rai RR, Govil A, Konar A, Goenka M, Agarwal M, Mukherjee J, Thorat V, Salunkhe S, Abraham P, Nagral A, Jhaveri A, Bhat N, Varghese JRSA, Ravishankar Reddy DC, Dhiman RK (2019). Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study. J Clin Exp Hepatol 9(4): 476-483. https://pubmed.ncbi.nlm.nih.gov/31516264/
Rega D, Aiko M, Peñaranda N, Urios A, Gallego JJ, Giménez-Garzó C, Casanova F, Fiorillo A, Cabrera-Pastor A, San-Miguel T, Ipiens C, Escudero-García D, Tosca J, Montón C, Ballester MP, Ballester J, Aparicio L, Ríos MP, Durbán L et al (2021) Patients with minimal hepatic encephalopathy show altered thermal sensitivity and autonomic function. Journal of Clinical Medicine 10(2):1–18. https://doi.org/10.3390/jcm10020239
Ridola L, Nardelli S, Gioia S, Riggio O (2018). Quality of life in patients with minimal hepatic encephalopathy. World J Gastroenterol 24(48): 5446-5453. https://www.ncbi.nlm.nih.gov/pubmed/30622374
Riggio, O., Amodio, P., Farcomeni, A., Merli, M., Nardelli, S., Pasquale, C., Pentassuglio, I., Gioia, S., Onori, E., Piazza, N., De Rui, M., Schiff, S. and Montagnese, S. (2015). A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis. Clin Gastroenterol Hepatol 13(7): 1346-1352. https://www.ncbi.nlm.nih.gov/pubmed/25572976
Riggio O, Ridola L, Pasquale C, Pentassuglio I, Nardelli S, Moscucci F, Merli M, Montagnese S, Amodio P, Merkel C (2011). A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol 9(7): 613-616.e611. https://www.cghjournal.org/article/S1542-3565(11)00314-4/pdf
Romero-Gomez, M., Cordoba, J., Jover, R., del Olmo, J. A., Ramirez, M., Rey, R., de Madaria, E., Montoliu, C., Nunez, D., Flavia, M., Company, L., Rodrigo, J. M. and Felipo, V. (2007). Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45(4): 879-885. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17393525
Román E, Córdoba J, Torrens M, Guarner C and Soriano G (2013). Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis. Eur J Gastroenterol Hepatol 25(1): 77-84. https://pubmed.ncbi.nlm.nih.gov/22954704/
Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, Guarner C, Soriano G (2011) Minimal hepatic encephalopathy is associated with falls. American Journal of Gastroenterology 106(3):476–482. https://doi.org/10.1038/ajg.2010.413
San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P, Ballester MP, Escudero-García D, Tosca J, Montón C, Ríos MP, Kosenko E, Felipo V, Tabares-Seisdedos R, Selva-Vera G, Montoliu C (2020) Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy. J Clin Med 9(7). https://doi.org/10.3390/jcm9072154
Santana Vargas ÁD, Higuera-De la Tijera, F. and Perez Hernandez, J. L. (2021). Auditory and visual P300 event-related potentials to detect minimal hepatic encephalopathy. Rev Esp Enferm Dig. https://pubmed.ncbi.nlm.nih.gov/33562990/
Schmid, M., Peck-Radosavljevic, M., König, F., Mittermaier, C., Gangl, A. and Ferenci, P. (2010). A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver Int 30(4): 574-582. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1478-3231.2010.02213.x
Schomerus, H. and Hamster, W. (2001). Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 16(1-2): 37-41. https://www.ncbi.nlm.nih.gov/pubmed/11726087
Seo, Y. S., Yim, S. Y., Jung, J. Y., Kim, C. H., Kim, J. D., Keum, B., An, H., Yim, H. J., Lee, H. S., Kim, C. D., Ryu, H. S. and Um, S. H. (2012). Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterol Hepatol 27(11): 1695-1704. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1440-1746.2012.07217.x
Sharma, P. and Sharma, B. C. (2014). A survey of patterns of practice and perception of minimal hepatic encephalopathy: a nationwide survey in India. Saudi J Gastroenterol 20(5): 304-308. http://www.ncbi.nlm.nih.gov/pubmed/25253366
Sharma, P., Sharma, B. C., Puri, V. and Sarin, S. K. (2007). Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 47(1): 67-73. https://www.ncbi.nlm.nih.gov/pubmed/17459511
Shrestha D, Rathi S, Grover S, Taneja S, Duseja A, Chawla YK, Dhiman RK (2020) Factors Affecting Psychological Burden on the Informal Caregiver of Patients With Cirrhosis: Looking Beyond the Patient. J Clin Exp Hepatol 10(1): 9-16. https://pubmed.ncbi.nlm.nih.gov/32025162/
Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S (2016). Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. J Gastroenterol Hepatol 31(6): 1203-1209. https://onlinelibrary.wiley.com/doi/abs/10.1111/jgh.13283
Soriano G, Roman E, Cordoba J, Torrens M, Poca M, Torras X, Villanueva C, Gich IJ, Vargas V, Guarner C (2012). Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 55(6): 1922-1930. https://www.ncbi.nlm.nih.gov/pubmed/22213000
Stawicka A, Jaroszewicz J, Zbrzeźniak J, Sołowianowicz N, Woszczenko A, Świderska M, Flisiak R (2020). Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy. Int J Environ Res Public Health 17(10). https://pubmed.ncbi.nlm.nih.gov/32455895/
Strebel H, Haller B, Sohn M, Schepp W, Gundling F (2020) Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE Portuguese Journal of Gastroenterology 27(6):391–403 https://www.scienceopen.com/document?vid=f3f595d6-06e4-4679-aaeb-6790212471b8
Sunil HV, Mittal BR, Kurmi R, Chawla YK, Dhiman RK (2012) Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy. J Clin Exp Hepatol 2(2):116–121 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940518/pdf/main.pdf
Taneja S, Dhiman RK, Khatri A, Goyal S, Thumbru KK, Agarwal R, Duseja A, Chawla Y (2012). Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver. J Clin Exp Hepatol 2(4): 306-314. https://pubmed.ncbi.nlm.nih.gov/25755452/
Tapper EB, Derstine B, Baki J, Su GL (2019). Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis. Dig Dis Sci 64(12): 3652-3659. https://pubmed.ncbi.nlm.nih.gov/31292783/
Tapper EB, Zhao L, Nikirk S, Baki J, Parikh ND, Lok AS, Waljee AK (2020). Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis. Am J Gastroenterol 115(12): 2017-2025. https://pubmed.ncbi.nlm.nih.gov/32773463/
Tryc AB, Pflugrad H, Goldbecker A, Barg-Hock H, Strassburg CP, Hecker H, Weissenborn K (2014). New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation. Liver Transpl 20(7): 807-814. https://pubmed.ncbi.nlm.nih.gov/24711070/
Tsai CF, Chu CJ, Huang YH, Wang YP, Liu PY, Lin HC, Lee FY, Lu CL (2015) Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. PLoS One 10(6):e0128437. https://doi.org/10.1371/journal.pone.0128437
Tsai CF, Chu CJ, Wang YP, Liu PY, Huang YH, Lin HC, Lee FY and Lu CL (2016). Increased serum interleukin-6, not minimal hepatic encephalopathy, predicts poor sleep quality in nonalcoholic cirrhotic patients. Aliment Pharmacol Ther 44(8): 836-845. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.13765?download=true
Tsai CF, Tu PC, Wang YP, Chu CJ, Huang YH, Lin HC, Hou MC, Lee FY, Liu PY, Lu CL (2019). Altered cognitive control network is related to psychometric and biochemical profiles in covert hepatic encephalopathy. Scientific reports 9(1). https://www.nature.com/articles/s41598-019-42957-6
Umapathy S, Dhiman RK, Grover S, Duseja A, Chawla YK (2014) Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol 109(7): 1011-1019. https://pubmed.ncbi.nlm.nih.gov/24777152/
Umemneku Chikere CM, Wilson K, Graziadio S, Vale L, Allen AJ (2019) Diagnostic test evaluation methodology: A systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard – An update. PLOS ONE 14(10):e0223832. https://doi.org/10.1371/journal.pone.0223832
Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS (2018) Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo. Eur J Gastroenterol Hepatol 30(8):951–958 https://pubmed.ncbi.nlm.nih.gov/29727385/
Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014). Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2): 715-735. https://www.ncbi.nlm.nih.gov/pubmed/25042402
Wang AJ, Peng AP, Li BM, Gan N, Pei L, Zheng XL, Hong JB, Xiao HY, Zhong JW, Zhu X (2017). Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients. World J Gastroenterol 23(34): 6321-6329. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603499/
Wang, J. Y., Bajaj, J. S., Wang, J. B., Shang, J., Zhou, X. M., Guo, X. L., Zhu, X., Meng, L. N., Jiang, H. X., Mi, Y. Q., Xu, J. M., Yang, J. H., Wang, B. S. and Zhang, N. P. (2019). Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. Journal of Digestive Diseases 20(10): 547-556. https://pubmed.ncbi.nlm.nih.gov/31448533/
Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34(5): 768-773. https://www.ncbi.nlm.nih.gov/pubmed/11434627
Wernberg CW, Schaffalitzky de Muckadell OB, Vilstrup H, Lauridsen MM (2019). Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis. PLoS One 14(12). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907801/
Wuensch T, Ruether DF, Zollner C, Mueller T, Jung T, Kaffarnik M, Kassner U, Schott E, Kiefer S, Pratschke J, Stockmann M and Jara M (2017). Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients. Eur J Gastroenterol Hepatol. http://www.ncbi.nlm.nih.gov/pubmed/28092641
Wunsch E, Koziarska D, Kotarska K, Nowacki P, Milkiewicz P (2013) Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study. Liver Int 33(9): 1332-1340. http://www.ncbi.nlm.nih.gov/pubmed/23651263
Wunsch E, Szymanik B, Post M, Marlicz W, Mydłowska M, Milkiewicz P (2011) Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study. Liver Int 31(7):980–984. https://doi.org/10.1111/j.1478-3231.2011.02465.x
Yoon EL, Jun DW, Jeong JY, Kim TY, Song DS, Ahn SB, Kim HY, Jung YK, Song MJ, Kim SE, Kim HS, Jeong SW, Kim SG, Lee TH, Cho YK, Kim JK, Ryu H (2019). Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy. Sci Rep 9(1): 8027. https://www.nature.com/articles/s41598-019-44503-w
Zeng X, Li XX, Shi PM, Zhang YY, Song Y, Liu Q, Wei L, Bajaj JS, Zhu YH, Li Y, Gu Y, Xie WF and Liu YL (2019) Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients. J Gastroenterol Hepatol 34(10): 1843-1850. https://pubmed.ncbi.nlm.nih.gov/30861191/
Zeng X, Zhang LY, Liu Q, Lu CH, Wei J, Shi ZW, Huang WR, Qu LH, Xu F, Wang XH, Shi PM, Tan Y, Tan W, Yuan ZL, Xia CY, Liu YL and Xie WF (2020) Combined Scores from the EncephalApp Stroop Test, Number Connection Test B, and Serial Dotting Test Accurately Identify Patients With Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol 18(7): 1618-1625.e1617. https://pubmed.ncbi.nlm.nih.gov/31712074/
Özel Coşkun BD, Özen M (2017) Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis. Turk J Gastroenterol 28(3): 191-196. https://pubmed.ncbi.nlm.nih.gov/28316320/
Availability of data and material
Not applicable.
Code availability
Not applicable.
Author information
Authors and Affiliations
Contributions
Not applicable.
Corresponding author
Ethics declarations
Conflicts of interest
None.
Ethics approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(DOCX 603 kb)
Rights and permissions
About this article
Cite this article
Hansen, M.K.G., Kjærgaard, K., Eriksen, L.L. et al. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy —current validation level and practical use. Metab Brain Dis 37, 589–605 (2022). https://doi.org/10.1007/s11011-022-00913-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-022-00913-w